BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toblli JE, Cao G, Rivas C, Kulaksiz H. Heart and iron deficiency anaemia in rats with renal insufficiency: the role of hepcidin. Nephrology (Carlton). 2008;13:636-645. [PMID: 18808386 DOI: 10.1111/j.1440-1797.2008.01019.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
2 Jankowska EA, Ponikowski P. Molecular Changes in Myocardium in the Course of Anemia or Iron Deficiency. Heart Failure Clinics 2010;6:295-304. [DOI: 10.1016/j.hfc.2010.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
3 Toblli JE, Di Gennaro F, Rivas C. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. Heart Lung Circ 2015;24:686-95. [PMID: 25666998 DOI: 10.1016/j.hlc.2014.12.161] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
4 Toblli JE, Cao G, Rivas C, Giani JF, Dominici FP. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation. International Journal of Cardiology 2016;212:84-91. [DOI: 10.1016/j.ijcard.2016.03.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
5 Toblli JE, Rivas C, Cao G, Giani JF, Funk F, Mizzen L, Dominici FP. Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model. Chemother Res Pract 2014;2014:570241. [PMID: 24876963 DOI: 10.1155/2014/570241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 van Breda GF, Bongartz LG, Zhuang W, van Swelm RP, Pertijs J, Braam B, Cramer MJ, Swinkels DW, Doevendans PA, Verhaar MC, Masereeuw R, Joles JA, Gaillard CA. Cardiac Hepcidin Expression Associates with Injury Independent of Iron. Am J Nephrol 2016;44:368-78. [PMID: 27771699 DOI: 10.1159/000449419] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
7 Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013;34:816-29. [PMID: 23100285 DOI: 10.1093/eurheartj/ehs224] [Cited by in Crossref: 200] [Cited by in F6Publishing: 183] [Article Influence: 20.0] [Reference Citation Analysis]
8 Garrido P, Reis F, Costa E, Teixeira-Lemos E, Parada B, Alves R, Piloto N, Sereno J, Figueiredo A, Pinto R, Carvalho L, Rocha-Pereira P, Belo L, Santos-Silva A, Teixeira F. Characterization of a rat model of moderate chronic renal failure--focus on hematological, biochemical, and cardio-renal profiles. Ren Fail 2009;31:833-42. [PMID: 19925293 DOI: 10.3109/08860220903151435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009;2:2. [PMID: 19133145 DOI: 10.1186/1755-8794-2-2] [Cited by in Crossref: 317] [Cited by in F6Publishing: 302] [Article Influence: 24.4] [Reference Citation Analysis]
10 Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872-1880. [PMID: 20570952 DOI: 10.1093/eurheartj/ehq158] [Cited by in Crossref: 356] [Cited by in F6Publishing: 295] [Article Influence: 29.7] [Reference Citation Analysis]
11 Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S, Macdougall IC, Weiss G, McMurray JJ, Anker SD. Iron status in patients with chronic heart failure. Eur Heart J. 2013;34:827-834. [PMID: 23178646 DOI: 10.1093/eurheartj/ehs377] [Cited by in Crossref: 146] [Cited by in F6Publishing: 114] [Article Influence: 14.6] [Reference Citation Analysis]
12 Rastmanesh R. Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration. Int J Gen Med 2011;4:647-56. [PMID: 21941450 DOI: 10.2147/IJGM.S23206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Prince PD, Lanzi CR, Toblli JE, Elesgaray R, Oteiza PI, Fraga CG, Galleano M. Dietary (-)-epicatechin mitigates oxidative stress, NO metabolism alterations, and inflammation in renal cortex from fructose-fed rats. Free Radic Biol Med 2016;90:35-46. [PMID: 26569027 DOI: 10.1016/j.freeradbiomed.2015.11.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]